about
The Genome Sequence of the Malaria Mosquito Anopheles gambiaeEvolutionary dynamics of immune-related genes and pathways in disease-vector mosquitoesOpen Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos ArylpyrrolesDesign and Synthesis of High Affinity Inhibitors of Plasmodium falciparum and Plasmodium vivax N -Myristoyltransferases Directed by Ligand Efficiency Dependent Lipophilicity (LELP)Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and BeyondMutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone AntimalarialsImaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug DiscoveryTargeting Plasmodium PI(4)K to eliminate malariaThe activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasitesHigh-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent MalariaA novel multiple-stage antimalarial agent that inhibits protein synthesisAnopheles gambiae PGRPLC-mediated defense against bacteria modulates infections with malaria parasites.The role of reactive oxygen species on Plasmodium melanotic encapsulation in Anopheles gambiae.Immune signaling pathways regulating bacterial and malaria parasite infection of the mosquito Anopheles gambiae.The Plasmodium eukaryotic initiation factor-2alpha kinase IK2 controls the latency of sporozoites in the mosquito salivary glands.Genome expression analysis of Anopheles gambiae: responses to injury, bacterial challenge, and malaria infectionSelective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporinDiscovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stagesA chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitorThe Plasmodium parasite--a 'new' challenge for insect innate immunity.Life cycle transcriptome of the malaria mosquito Anopheles gambiae and comparison with the fruitfly Drosophila melanogasterHigh-Throughput Assay and Discovery of Small Molecules that Interrupt Malaria Transmission.A broad analysis of resistance development in the malaria parasiteTrisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials.Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy.Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes.Infection of laboratory-colonized Anopheles darlingi mosquitoes by Plasmodium vivax.Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle.A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.3-Hydroxy-N'-arylidenepropanehydrazonamides with Halo-Substituted Phenanthrene Scaffolds Cure P. berghei Infected Mice When Administered Perorally.Immunity-related genes and gene families in Anopheles gambiae.Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity.Synthesis of (+)-7,20-Diisocyanoadociane and Liver-Stage Antiplasmodial Activity of the Isocyanoterpene Class.Spatially restricted expression of candidate taste receptors in the Drosophila gustatory system.Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesis.Open-source discovery of chemical leads for next-generation chemoprotective antimalarials
P50
Q22065828-F43018A7-0258-43E7-B701-24E20543F79EQ24674617-9FBBD630-CA02-44DB-9C18-2146AC4400FAQ26883657-EF0602FF-CCD3-4C58-B2E0-90F31A4F421CQ27682285-3F019274-CF71-4164-A902-E7F63DC32B7EQ27826351-0F621A0D-E228-489C-99A4-7BF6C23DC916Q27861952-760E098D-9A98-46B2-B628-5CBA1EA7A720Q27861956-317033D1-D170-4539-9CD6-F2246C5A3BE7Q27974482-3E67A308-B17F-4078-B6F6-A8A01B8F8829Q28480979-60591B56-F71D-4796-9281-0DF3F6F44C0EQ28829342-49EC4A13-5585-4B72-96F9-03E66AF14D45Q30044020-32E9D933-4137-47BF-81D4-962E84E524BBQ33491549-1F6DE36B-984F-44B8-8D03-21F9F8F11194Q33715530-7957CCAF-E4D0-40D3-AA03-B6F62AEA6420Q33914129-29EA88FE-2F3B-475E-A0C6-3C604EADCBCBQ33979926-C4B9F577-2127-4DB1-9B47-A97E520C985CQ34066024-045E8269-E773-4787-A81D-ACF9CBFB6127Q34306714-A2D3280C-63F4-46B2-ACE8-40C99CB0BA47Q35182742-FB215065-8626-446B-BE87-2E63777C9842Q35563452-19C780E5-F15E-4FD6-870A-63BE55B6328AQ35975151-26461B99-070A-4D91-B5D8-AF0A67B00D0FQ36090154-75A71012-82A0-4C91-B955-D8675E0E0F8CQ36492518-F374E758-695D-43FC-BE91-B3086C031296Q37017711-96C28AAD-58BA-4812-823D-0C28E335CB7DQ37101499-48188EAB-33F9-49D1-98D9-AF947B14E188Q37412029-102560C1-4F15-484B-B2A0-DF31F4B4AD67Q37414137-C11FEF4D-FFF4-4627-BCC2-88671C9D0A88Q37680691-6B42E62D-00BD-48C5-B64E-05513BE21BB0Q39164423-69FD8CF1-076A-420B-B04C-00A2AC31B25AQ39164432-925CC70E-AF62-4E4E-8393-C9CAA2B318DBQ39172819-C25ABF7E-3F05-4BFA-AA0C-3CD1C9293CEEQ44149321-92E93238-CDE8-4935-BF4E-7B06939CC3B0Q46124569-824B0D64-C675-4949-961B-C5BA92A06F9BQ46651034-A7237DF6-388A-43A0-A8EC-A9FFF1EEC1FEQ47070178-A7E19F42-7338-4707-BAB8-987DB793BE1AQ51711730-748F30AD-75A9-4B2F-B130-9240B0B3349CQ64356851-709F7845-A49B-4EEB-B6C3-482E788B3F37
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Stephan Meister
@ast
Stephan Meister
@en
Stephan Meister
@es
Stephan Meister
@nl
Stephan Meister
@sl
type
label
Stephan Meister
@ast
Stephan Meister
@en
Stephan Meister
@es
Stephan Meister
@nl
Stephan Meister
@sl
prefLabel
Stephan Meister
@ast
Stephan Meister
@en
Stephan Meister
@es
Stephan Meister
@nl
Stephan Meister
@sl
P1053
M-6608-2014
P106
P1960
MMHd4gIAAAAJ
P2038
Stephan_Meister
P21
P31
P3829
P496
0000-0003-2436-7037